CDHA CAAR

“Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional),” (PAR-18-747, National Institute on Aging, application deadlines June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional),” (PAR-18-745).

grants.nih.gov/grants/guide/pa-files/PAR-18-747.html

A. “Geriatrics and Clinical Gerontology Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Not Allowed),” (PA-18-751, National Institute on Aging, application due date July 16, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-751.html

B. “Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18),” (PA-18-750, Agency for Healthcare Research and Quality, application due dates Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PA-18-750.html

C. “Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed),” (PAR-18-749, National Institute on Aging, application due dates Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-18-749.html

“Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional),” (PAR-18-740, is a reissue of PAR-17-254, National Institute on Aging, in conjunction with other agencies, application deadline August 31, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-740.html

“Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional),” (PA-18-738, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional),” (PA-18-739).

grants.nih.gov/grants/guide/pa-files/PA-18-738.html

“New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional),” (PAS-18-730, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAS-18-730.html

A. “Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional),” (PA-18-722, a reissue of PA-14-334, National Institute of Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional),” (PA-18-723).

grants.nih.gov/grants/guide/pa-files/PA-18-722.html

B. “Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional),” (PA-18-729, a reissue of PA-17-478, National Institute of Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional),” (PA-18-728).

grants.nih.gov/grants/guide/pa-files/PA-18-729.html

“NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer’s Disease Patient Registry Cooperative Agreement Awards (U01 – Clinical Trial Not Allowed),” (PAR-18-715, National Institute on Aging, application deadlines Feb. 5, June 5, and October 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-715.html

A. “Native American Elder Justice Initiative,” (HHS-2018-ACL-AOA-IERC-0292, application deadline June 15, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301902

B. “Information and Planning: Understanding the Capacity of the Aging Network,” (HHS-2018-ACL-AOA-PPUC-0297, application deadline June 18, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301901

C. “National Alzheimer’s Call Center,” (HHS-2018-ACL-AOA-ACRC-0296, application deadline May 25, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301900

“Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional),” (PA-18-713, a reissue of PA-17-098, National Institute on Aging, in conjunction with other agencies, application deadline May 7, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-713.html

A. “Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp),” (PA-18-713, a reissue of PA-17-098, National Institute on Aging, in conjunction with other agencies, application deadline May 7, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-713.html

B. “BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed),” (RFA-NS-18-019, a reissue of RFA-NS-17-004, National Institute on Aging, in conjunction with other agencies, application deadlines May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-019.html

C. “BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed),” (RFA-NS-18-020, a reissue of RFA-NS-17-003, National Institute on Aging, in conjunction with other agencies, application deadlines May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html

“Selective Cell and Network Vulnerability in Aging and Alzheimer’s Disease (R01 – Clinical Trial Not Allowed),” (PAR-18-706, a reissue of PAR-17-047, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-706.html

A. “Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54),” (RFA-OD-18-004, a reissue of RFA-OD-11-003, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-18-004.html

B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33),” (PA-18-672, a reissue of PA-16-310, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-672.html

C. “Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-18-673, a reissue of PA-16-306, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-673.html

A. “Pathway and Target Identification for Alzhiemer’s Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed),” (PAR-18-661, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-661.html

B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31),” (PA-18-671, a reissue of PA-16-309, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-671.html

C. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32),” (PA-18-670, a reissue of PA-16-307, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-670.html

D. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-18-668, a reissue of PA-16-305, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-668.html

E. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31),” (PA-18-666, a reissue of PA-16-308, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-666.html

F. “Administrative Supplement for Research on Sex/Gender Influences (Admin Supp – Clinical Trial Optional),” (PA-18-658, a reissue of PA-17-078, National Institute on Aging, in conjunction with other agencies, application deadline March 26, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-658.html

G. “Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required),” (RFA-AG-18-031, National Institute on Aging, application deadline April 30, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-031.html

A. “Alzheimer & Disease Initiative – Specialized Supportive Services (ADI-SSS) Project Financed Solely by 2018 Prevention and Public Health Funds (PPHF 2018),” (HHS-2018-ACL-AOA-ALGG-0284, application deadline June 18, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=300567

B. “Alzheimer & Disease Supportive Services Program (ADSSP): Creating and Sustaining Dementia-Capable Service Systems for People with Dementia and their Family Caregivers,” (HHS-2018-ACL-AOA-DS-0283, application deadline June 29, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=300566

A. “Dementia Care and Caregiver Support Interventions (R01 – Clinical Trial Required),” (RFA-AG-18-030, National Institute on Aging, application deadline April 10, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-030.html

B. “Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed),” (RFA-MD-18-006, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-MD-18-006.html

C. “Structural Biology of Alzheimer’s Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed),” (RFA-NS-18-015, National Institute of Neurological Disorders and Stroke, application deadline April 30, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-015.html

D. “Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed),” (RFA-NS-18-024, National Institute on Aging, in conjunction with other agencies, application deadline April 17, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-024.html

E. “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed),” (PA-18-648, National Institute on Aging, in conjunction with other agencies, application deadlines April 12, August 12, and Dec. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-648.html

F. “Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required),” (PAR-18-630, a reissue of PAR-17-056, National Institute on Aging, in conjunction with other agencies, application deadlines April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019).

grants.nih.gov/grants/guide/pa-files/PAR-18-630.html

G. “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional),” (PAR-18-644, a reissue of PAR-16-368, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional),” (PAR-18-645).

grants.nih.gov/grants/guide/pa-files/PAR-18-644.html

“Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional),” (PAR-18-596, National Institute on Aging, in conjunction with other agencies, application deadline April 17, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-596.html

“Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R41/R42 – Clinical Trials Optional),” (PAR-18-587, National Institute on Aging, application deadlines April 10, 2018, January 8, 2019, and January 8, 2020). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R43/R44 – Clinical Trial Optional),” (PAR-18-588).

grants.nih.gov/grants/guide/pa-files/PAR-18-587.html

A. “Alzheimer’s Disease Research Centers (P30 – Clinical Trials Not Allowed),” (RFA-AG-19-001, a reissue of RFA-AG-16-018, National Institute on Aging, deadline for applications June 4, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-001.html

B. “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed),” (PA-18-586, a reissue of PA-16-288, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-001.html

C. “Successor-in-Interest (Type 6 Parent Clinical Trial Optional),” (PA-18-589, a reissue of PA-16-286, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-589.html

D. “Change of Grantee Organization (Type 7 Parent Clinical Trial Optional),” (PA-18-590, a reissue of PA-16-285, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-590.html

E. “Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp – Clinical Trial Optional),” (PA-18-591, a reissue of PA-16-287, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-591.html

F. “Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed),” (PA-18-592, a reissue of PA-16-289, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-592.html

G. “Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R43/R44 – Clinical Trial Optional),” (PAR-18-588, National Institute on Aging, application deadlines April 10, 2018, January 8, 2019, and January 8, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-588.html

“Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 – Clinical Trial Required),” (PAR-18-585, a reissue of RFA-AG-17-065, National Institute on Aging, application deadlines March 27, 2018; February 20, 2019; and February 20, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-585.html

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-18-576, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, Jan. 5, and April 5). Note: There are three companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-18-575); “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-18-574); and, “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-18-573).

grants.nih.gov/grants/guide/pa-files/PA-18-576.html

“Research to Evaluate Medication Management of Opioids and Benzodiazepines to Reduce Older Adult Falls,” (RFA-CE-18-004, application deadline March 23, 2018).

www.grants.gov/custom/viewOppDetails.jsp?oppId=297573

“Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 Clinical Trial Optional),” (PAR-18-581, National Institute on Aging, funding deadlines March 29, 2018; June 8, 2018; February 8, 2019; June 7, 2019; February 7, 2020; and June 8, 2020). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 Clinical Trial Not Allowed),” (PAR-18-582)

grants.nih.gov/grants/guide/pa-files/PAR-18-581.html

“Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional),” (PA-18-570, a reissue of PA-15-049, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, June 5, and Oct. 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional),” (PA-18-571); and, “Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional),” (PA-18-572).

grants.nih.gov/grants/guide/pa-files/PA-18-570.html

A. “Partnership for Aging and Cancer Research (U01 Clinical Trial Not Allowed),” (PAR-18-552, National Institute on Aging, in conjunction with other agencies, application deadline June 8, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-552.html

B. “Basic and Translational Research on Decision Making in Aging and Alzheimer’s Disease (R01 – Clinical Trial Optional),” (PAR-18-544, a reissue of PAR-16-448, National Institute on Aging, first application deadline March 29, 2018). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Basic and Translation Research on Decision Making in Aging and Alzheimer’s Disease (R21 – Clinical Trial Optional),” (PAR-18-538).

grants.nih.gov/grants/guide/pa-files/PAR-18-544.html

C. “Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease and AD Related Dementias (T32 – Clinical Trial Not Allowed),” (PAR-18-524, a reissue of RFA-AG-17-063, National Institute on Aging, first application deadline March 29, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-524.html

D. “Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 – Clinical Trial Optional),” (PA-18-545, a reissue of of PA-15-347, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-545.html

E. “Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed),” (PAR-18-514, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and April 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed),” (PAR-18-512).

grants.nih.gov/grants/guide/pa-files/PAR-18-514.html

F. “Sensory and motor system changes as predictors of preclinical Alzheimer’s disease (R01 – Clinical Trial Not Allowed),” (PAR-18-519, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-519.html

G. “Human Cell Biology of Alzheimer’s Disease Genetic Variants (R01 – Clinical Trial Not Allowed),” (PAR-18-516, a reissue of RFA-AG-17-053, National Institute on Aging, first application deadline March 29, 2018: other deadlines: June 8, 2018; October 9, 2018; February 8, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 7, 2020; and October 7, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-516.html

A. “2018 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs Financed by the Prevention and Public Health Fund,” (HHS-2018-ACL-AOA-CSSG-0256, application deadline April 30, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=299734

B. “2018 Evidence-Based Falls Prevention Program financed by Prevention and Public Health Fund,” (HHS-2018-ACL-AOA-FPSG-0255, application deadline April 30, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=299735

A. “Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required),” (PAR-18-513, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Alzheimer’s Clinical Trials Consortium (ACTC) (U24),” (RFA-AG-17-005).

grants.nih.gov/grants/guide/pa-files/PAR-18-513.html

B. “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional),” (PA-18-348, a reissue of PA-15-017, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed),” (PA-18-473); and, “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional),” (PA 18-347).

grants.nih.gov/grants/guide/pa-files/PA-18-348.html

A. “Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed),” (PAR-18-497, National Institute on Aging, application deadlines March 26, 2018, June 6, 2018; October 7, 2018; February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-497.html

B. “Advancing the Science of Geriatric Palliative Care (R21 – Clinical Trial Optional),” (PA-18-503, a reissue of PA-17-226, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-503.html

C. “Advancing the Science of Geriatric Palliative Care (R01 – Clinical Trial Optional),” (PA-18-502, a reissue of PA-17-225, National Institute on Aging, in conjunction with other agences, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-502.html

D. “BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 – Clinical Trials Optional),” (RFA-NS-18-018, National Institute on Aging, in conjunction with other agencies, application deadlines February 23, 2018, June 6, 2018, October 4, 2018, February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-018.html

E. “BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 – Clinical Trials Not Allowed),” (RFA-NS-18-014, National Institute on Aging, in conjunction with other agencies, application deadlines March 15, 2018; July 17, 2018; July 15, 2019).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-014.html

F. “Deciphering the Molecular Landscape of Lung Aging in Humans (U01 – Clinical Trial Not Allowed),” (RFA-HL-19-012, National Heart, Lung, and Blood Institute, application deadline February 27, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-012.html

G. “From Association to Function in the Alzheimer’s Disease Post-Genomics Era (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-026, a reissue of RFA-AG-17-010, National Institute on Aging, application deadline March 28, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-026.html

H. “Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer’s Disease (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-027, a reissue of RFA-AG-17-051, National Institute on Aging, application deadline March 26, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-027.html

I “Pragmatic Trials of Managing Multimorbidity in Alzheimer’s Disease (R01 Clinical Trial Required),” (RFA-AG-18-028, a reissue of RFA-AG-17-059, National Institute on Aging, application deadline March 26, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-028.html

J. “Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s Disease Risk (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-029, a reissue of RFA-AG-17-061, National Institute on Aging, application deadline March 26, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-029.html

“Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed),” (PA-18-504, a reissue of PA-16-200, National Institute on Aging, in conjunction with other agencies, application deadlines, Feb. 25, June 25, and Oct. 25).

grants.nih.gov/grants/guide/pa-files/PA-18-504.html

A. “NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed),” (PA-18-488, a reissue of PA-16-162, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PA-18-488.html

B. “NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed),” (PA-18-489, a reissue of PA-16-161, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PA-18-489.html

A. “Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-18-187, a reissue of PAS-17-064, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAS-18-187.html

B. “Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-18-188, a reissue of PAS-17-065, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAS-18-188.html

C. “T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional),” (PAR-18-183, a reissue of PAR-16-375, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-183.html

D. “T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional),” (PAR-18-184, a reissue of PAR-16-376, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-184.html

E. “Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional),” (PAR-18-185, a reissue of PAR-17-108, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-185.html

F. “Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional),” (PAR-18-186, a reissue of PAR-17-107, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-186.html

A. “Advanced Rehabilitation Research Training (ARRT) Program – Health and Function,” (HHS-2018-ACL-NIDILRR-ARHF-0241, application deadline January 16, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=298538

B. “Advanced Rehabilitation Research Training (ARRT) Program – Community Living and Participation,” (HHS-2018-ACL-NIDILRR-ARCP-0240, application deadline January 16, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=298537

A. “Education and Health: New Frontiers (R01)- Clinical Trial Optional,” (PAR-18-387, a reissue of PAR-16-078, National Institute on Aging, in conjunction with other agencies, deadlines for applications Feb. 5, June 5, and Oct. 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Education and Health: New Frontiers (R03) – Clinical Trial Optional,” (PAR-18-388); and, “Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional,” (PAR-18-378).

grants.nih.gov/grants/guide/pa-files/PAR-18-387.html

B. “Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional,” (PAR-18-352, a reissue of PAR-16-260, National Institute on Aging, conjunction with other agencies, deadlines for applications Feb. 5, June 5, and Oct. 5).  Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “• Education and Health: New Frontiers (R21)- Clinical Trial Optional,” (PAR-18-362).

grants.nih.gov/grants/guide/pa-files/PAR-18-352.html

C. “Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32),” (PA-18-403, a reissue of PA-16-152, National Insitute on Aging, in conjunction with other agencies, deadline for applications Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PA-18-403.html

D. “Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35),” (PA-18-404, a reissue of PA-16-151, National Insitute on Aging, in conjunction with other agencies, deadline for applications Jan. 25, May 25, and Sept. 25)

grants.nih.gov/grants/guide/pa-files/PA-18-404.html

E. “Midcareer Investigator Award in Patient-Oriented Research (Parent K24 – Clinical Trial Required),” (PA-18-393, a reissue of PA-16-206, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-393.html

F. “Midcareer Investigator Award in Patient-Oriented Research (Parent K24 – No Independent Clinical Trials),” (PA-18-394, a reissue of PA-16-206, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-394.html

G. “Mentored Quantitative Research Development Award (Parent K25 – Clinical Trial Required),” (PA-18-395, a reissue of PA-16-194, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-395.html

H. “Mentored Quantitative Research Development Award (Parent K25 – No Independent Clinical Trials),” (PA-18-396, a reissue of PA-16-194, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-396.html

I. “Mentored Patient-Oriented Research Career Development Award (Parent K23 – Clinical Trial Required),” (PA-18-374, a reissue of PA-16-198, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-374.html

J. “Mentored Clinical Scientist Research Career Development Award (Parent K08 – No Independent Clinical Trials),” (PA-18-373, a reissue of PA-16-191, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-373.html

K. “Independent Scientist Award (Parent K02 – Independent Clinical Trial Required),” (PA-18-370, a reissue of PA-16-192, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-370.html

L. “Independent Scientist Award (Parent K02 – Independent Clinical Trials Not Allowed),” (PA-18-371, a reissue of PA-16-192, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-371.html

M. “Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Required),” (PA-18-372, a reissue of PA-16-191, National Institute on Aging, in conjunction with other agencies, deadline for applications Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-372.html

A. “Mentored Research Scientist Development Award (Parent K01 – Independent Clinical Trial Not Allowed),” (PA-18-369, a reissue of PA-16-190, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-369.html

B. “Mentored Research Scientist Development Award (Parent K01 – Independent Clinical Trial Required),” (PA-18-363, a reissue of PA-16-190, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 12, June 12, and Oct. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-363.html

A. “Pathogenesis of Age-Related HIV Neurodegeneration (R01 Clinical Trial Not Allowed),” (RFA-AG-18-023, National Institute on Aging, application deadline February 9, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-023.html

B. “Mechanistic Basis of Diffuse White Matter Disease and Small Vessel Pathology in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01),” (PAR-18-413, National Institute on Aging, in conjunction with other agencies, application deadline March 23, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-413.html

C. “Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional),” (PAR-18-227, a reissue of PAR-16-266, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-227.html

D. “T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21 Clinical Trial Optional),” (PAR-18-178, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PAR-18-178.html

E. “T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21 Clinical Trial Optional),” (PAR-18-177, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PAR-18-177.html

A. “Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional),” (PA-18-134, a reissue of PA-15-098, National Institute on Aging, in conjunction with other agencies, application deadlines of Feb. 5, June 5, and October 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional),” (PA-18-153).

grants.nih.gov/grants/guide/pa-files/PA-18-134.html

B. “Research on Informal and Formal Caregiving for Alzheimer’s Disease (R01 Clinical Trial Optional),” (PAR-18-027, a reissue of PAR-15-348, National Institute on Aging, in conjunction with other agencies, application deadlines of Feb. 5, June 5, and October 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research on Informal and Formal Caregiving for Alzheimer’s Disease (R21 Clinical Trial Optional),” (PAR-18-179).

grants.nih.gov/grants/guide/pa-files/PAR-18-027.html

C. “Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional),” (PA-18-005, a reissue of PA-17-110, National Institute on Aging, in conjunction with other agencies, application deadlines of Feb. 5, June 5, and October 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional),” (PA-18-015).

grants.nih.gov/grants/guide/pa-files/PA-18-005.html

D. “Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional),” (PA-18-061, a reissue of PA-17-196, National Institute on Aging, in conjunction with other agencies, application deadlines of Feb. 5, June 5, and October 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional),” (PA-18-080); and, “Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional),” (PA-18-079).

grants.nih.gov/grants/guide/pa-files/PA-18-061.html

E. “Dissemination and Implementation Research in Health (R01 Clinical Trial Optional),” (PAR-18-007, a reissue of PAR-16-238, National Institute on Aging, in conjunction with other agencies, application deadlines of Feb. 5, June 5, and October 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Dissemination and Implementation Research in Health (R03),” (PAR-16-237); and, “Dissemination and Implementation Research in Health (R21 Clinical Trial Optional),” (PAR-18-017).

grants.nih.gov/grants/guide/pa-files/PAR-18-007.html

F. “Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional),” (PAR-18-174, a reissue of PAR-15-174, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-174.html

G. “Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01 Clinical Trial Optional),” (PA-18-147, a reissue of PA-17-014, National Institute of Nursing Research, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional),” (PA-18-165).

grants.nih.gov/grants/guide/pa-files/PA-18-147.html

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in National Disasters Declared by the President Department of Health and Human Services,” (HHS-2018-ACL-AOA-DASG-0237, application deadline September 14, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=298224

A. “Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional),” (PAR-18-296, a reissue of PAR-16-143, National Institute on Aging, application deadline Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-18-296.html

B. “Pilot Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional),” (PAR-18-175, a reissue of PAR-16-365, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-175.html

C. “Improving Quality of Care and Quality of Life for Persons with Alzheimer’s Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional),” (PAS-18-030, a reissue of PAS-17-027, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAS-18-030.html

D. “Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional),” (PAR-18-026, a reissue of PAR-15-175, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-026.html

E. “Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional),” (PA-18-025, a reissue of PA-17-073, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-025.html

F. “Clarifying the Relationship between Delirium and Alzheimer’s Disease and Related Dementias (R21/R33 Clinical Trial Optional),” (PAR-18-181, a reissue of PAR-17-037, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-181.html

A. “Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional),” (RFA-AG-18-019, National Institute on Aging, application deadline February 21, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-019.html

B. “Role of Peripheral Proteostasis on Brain Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-18-020, a reissue of RFA-AG-17-050, National Institute on Aging, application deadline February 9, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-020.html

C. “Immunity in the Elderly (R01) Clinical Trial Optional,” (RFA-AI-17-037, a reissue of RFA-AI-12-038, National Institute on Aging, in conjunction with other agencies, deadline for applications February 22, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AI-17-037.html

D. “Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) – Clinical Trial Not Allowed,” (PA-18-408, a reissue of PA-13-237, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 15, June 16, and October 16).

grants.nih.gov/grants/guide/pa-files/PA-18-408.html

E. “Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) – Clinical Trial Not Allowed,” (PA-18-409, a reissue of PA-13-236, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-409.html

F. “Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer’s Disease and/or Alzheimer’s Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed),” (PAR-18-326, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-326.html

G. “Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer’s Disease and/or Alzheimer’s Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed),” (PAR-18-329, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and Apr. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-329.html

H “NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional),” (PAR-18-030, a reissue of PAR-16-359, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-18-030.html

A. “NBER Fellowships in Aging and Health Research,” (application deadline December 3, 2017).

www.nber.org/programs/ag/cahr/training.html

B. “NBER Fellowships in Disability Policy Research,” (application deadline December 3, 2017).

www.nber.org/aging/drc/training_drc.html

C. “NBER Post-Doctoral Fellowship Program on the Economics of an Aging Workforce,” (application deadline December 3, 2017).

www.nber.org/callforpapers/PostDocAgingWorkforce2017.html

“Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer’s Disease and/or Alzheimer’s Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed),” (PAR-18-326, National Institute on Aging, application deadlines Sept. 5, January 5, and April 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer’s Disease and/or Alzheimer’s Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed),” (PAR-18-329).

grants.nih.gov/grants/guide/pa-files/PAR-18-326.html

“Simulation Modeling and Systems Science to Address Health Disparities (R01 Clinical Trial Not Allowed),” (PAR-18-331, National Institute on Aging, in conjunction with other agencies, application deadlines: January 10 2018; June 6, 2018; January 8, 2019; June 7, 2019).

grants.nih.gov/grants/guide/pa-files/PAR-18-331.html

“2018 Steven H. Sandell Grant Program,” (application deadline January 31, 2018). Information about the application can be found at:

crr.bc.edu/about-us/grant-programs/steven-h-sandell-grant-program-2/

“Testing Interventions for Health-Enhancing Physical Activity (R01 – Clinical Trial Optional),” (PAR-18-324, a reissue of PAR-14-315, National Institute on Aging, in conjunction with other agencies, application deadlines February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; October 5, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-324.html

A. “Developing Interventions for Health-Enhancing Physical Activity (R21/R33 – Clinical Trial Optional),” (PAR-18-307, a reissue of PAR-14-321, National Institute on Aging, in conjunction with other agencies, application deadlines May 7, 2018; January 7, 2019; September 7, 2019; May 7, 2020; January 7, 2021).

grants.nih.gov/grants/guide/pa-files/PAR-18-307.html

B. “Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp),” (PA-18-314, a reissue of PA-16-414, , National Institute on Aging, in conjunction with other agencies, application deadline December 18, 2017).

grants.nih.gov/grants/guide/pa-files/PA-18-314.html

C. “Testing Interventions for Health-Enhancing Physical Activity (R01 – Clinical Trial Optional),” (PA-17-306, a reissue of PAR-14-315, National Institute on Aging, in conjunction with other agencies, application deadlines: February 5, 2018; October 5, 2018; June 5, 2019; February 5, 2020; October 5, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-17-306.html

A. “BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed),” (RFA-EB-17-004, a Reissue of RFA-EB-17-002, National Institute on Aging, in conjunction with other agencies, application deadlines December 20, 2017 and December 11, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-17-004.html

B. “BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01),” (RFA-NS-18-010, a reissue of RFA-NS-17-019, National Institute on Aging, in conjunction with other agencies, application deadline January 19, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-010.html

C. “BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed),” (RFA-EB-17-003, a reissue of RFA-EB-17-001, National Institute on Aging, in conjunction with other agencies, application deadlines December 20, 2017 and December 11, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-17-003.html

A. “Development of Valid Reliable Markers of Aging-Related Biologic Mechanisms for Human Studies (U01),” (RFA-AG-18-018, National Institute on Aging, application deadline January 30, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-018.html

B. “BRAIN Initiative: Tools to target, identify and characterize non-neuronal cells in the brain (R01 Clinical Trial Not Allowed),” (RFA-DA-18-018, National Institute on Aging, in conjunction with other agencies, application deadline February 1, 2018 and October 4, 2018)

grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-018.html

C. “Biology Of Aging Dental, Oral And Craniofacial Tissues (R01 – Clinical Trial Not Allowed),” (RFA-DE-18-009, National Institute of Dental and Craniofacial Research, deadline for application for January 31, 2018). Note: Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Biology Of Aging Dental, Oral And Craniofacial Tissues (R21 – Clinical Trial Not Allowed),” (RFA-DE-18-010).

grants.nih.gov/grants/guide/rfa-files/RFA-DE-18-009.html

D. “NINDS Morris K. Udall Centers of Excellence for Parkinson’s Disease Research (P50),” (RFA-NS-18-002, National Institute of Neurological Disorders and Stroke, application deadline December 15, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-002.html

E. “Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01),”
(RFA-NS-18-003, National Institute on Aging, in conjunction with other agencies, deadline for application December 11, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-003.html

F. “Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels (R01),” (RFA-NS-18-004, National Institute on Aging, in conjunction with other agencies, application deadline December 11, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-004.html

G. “BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24),” (RFA-NS-18-005, National Institute on Aging, in conjunction with other agencies, deadline for applications February 9, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-005.html

“Research on Transgender Health (R01),” (PA-17-478, National Institute on Aging, in conjunction with other agencies application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research on the Health of Transgender and Gender Nonconforming Populations (R21),” (PA-17-477).

grants.nih.gov/grants/guide/pa-files/PA-17-478.html

“BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01),” (RFA-MH-18-505, National Institute on Aging, in conjunction with other agencies, application deadlines Dec. 7, 2017 and Nov. 13, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-505.html

A. “NIH Blueprint for Neuroscience Research: Dynamic Neuroimmune Interactions in the Transition from Normal CNS Function to Disorders (R01),” (RFA-AA-18-007, National Institute on Aging, in conjunction with other agencies, deadline for applications December 7, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AA-18-007.html

B. “BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01),” (RFA-MH-18-500, National Institute on Aging, in conjunction with other agencies, deadline for applicaitons December 7, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-500.html